𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma

✍ Scribed by H. Nielsen; M. Rørth; J. Bennedsen

Publisher
Springer-Verlag
Year
1985
Tongue
English
Weight
398 KB
Volume
19
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

✦ Synopsis

The chemotactic responsiveness of blood monocytes was tested in 16 patients with nonseminomatous testicular carcinoma before, during, and after chemotherapy. All the patients initially had monocyte chemotaxis within the normal range. No correlation with the histology of the tumor, the clinical stage, or the presence in serum of a-fetoprotein and human chorionic gonadotropin was observed. Plasma from the patients did not inhibit the chemotaxis of normal monocytes, and serum from the patients contained no chemotactic factor inhibitor. During intensive chemotherapy with cis-platinum, bleomycin, and vinblastine a reversible defect in chemotaxis occurred without correlation to the development of fever. Two months after the completion of chemotherapy the chemotactic responsiveness was unchanged compared with pretreatment values. In conclusion, this study shows normal monocyte chemotaxis in patients with testicular carcinoma, which is in • contrast to reports on a variety of other solid tumors.

📜 SIMILAR VOLUMES

Some effects of combination chemotherapy
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma
✍ Sijtze Meijer; Dirk Th. Sleijfer; Nanno H. Mulder; Wim J. Sluiter; Jan Marrink; 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

Renal function in 24 patients with-disseminated nonseminomatous testicular carcinoma treated with combination chemotherapy including cis-platinum was examined prospectively. Renal function was monitored by several determinations of glomerular filtration rate (GFR), effective renal plasma flow (ERPF)

Retroperitoneal surgery in patients with
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor
✍ Dr. Hanne Qvist; Sophie Dorothea Fosså; Sigurd Ous; Hans H. Lien; Anna E. Stenwi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

In the period 1980-1991, 78 patients with advanced nonseminomatous testicular cancer underwent retroperitoneal lymphadenectomy for postchemotherapy residual masses <2 cm. To decrease the frequency of "dry ejaculation" in these patients with no or limited residual disease, the extent of dissection wa

Normalization of defective monocyte chem
Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung
✍ H. Nielsen; J. Bennedsen; P. Dombernowsky 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 327 KB

Monocyte chemotactic responsiveness (MCR) in 14 patients with small cell anaplastic bronchogenic carcinoma was depressed before treatment compared with the MCR in 28 normal controls (P = 0.00004). MCR was subsequently monitored during combination chemotherapy and after 6 months the MCR had become no

Treatment experience with nonseminomatou
Treatment experience with nonseminomatous testicular cancer in patients with stage II and stage III disease
✍ H. Grant Taylor; Archie W. Brown Jr.; William M. Butler; Martin D. Weltz; Jeffre 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

Thirty-eight patients with nonseminomatous testicular cancer were treated with cis-platinum, bleomycin, and vinblastine in combination without a prolonged maintenance phase. Twentysix patients with Stage Ill disease were treated. Seventy-six percent of those patients treated achieved complete remiss